|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
������Ƥ���� |
|
����ϸ������ |
| ��������������� | |
|
��ƽƽ���� |
|
̷��Ȫ��У |
|
��ѧ����У |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
����ϸ�������������Ƥ����
��ƽƽ����, ̷��Ȫ��У, ��ѧ����У
����ҽ�ƴ�ѧƤ�����о���������ҽԺƤ�������Բ���
������40��������ϸ�����ӡ�20��������ϸ���������塣�ڹ�����Ƥ������,RANTES��eotaxin������Ҫ������������ϸ��������ϸ�����ӡ�������Ҫ��������ϸ�����Ӽ��������ڹ�����Ƥ�����е������Լ��������ϸ���������Ƶ��²��ԡ�
[2] Wong M, Fish EN. RANTES and MIP-1alpha activate stats in T cells. J Biol Chem, 1998,273(1):309-314.
[3] Haribabu B, Richardson RM, Fisher I, et al. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J Biol Chem, 1997,272(45):28726-28731.
[4] Zhao J, Ma L, Wu YL, et al. Chemokine receptor CCR5 functionally couples to imhibitory G proteins and undergoes desensitization. J Cell Biochem, 1998,71(1):36-45.
[5] Zimmermann N, Conkright J J, Rothenberg ME, et al. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J Biol Chem,1999,274(18):12611-12618.
[6] Oppemann M, Mack M, Proudfoot AE, et al. Differential effects of CC chemokines on CC chemokine receptor 5(CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J Biol Chem,1999,274(13):8875-8885.
[7] Turner SJ, Domin J, Waterfield MD, et al. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p1l0 phosphatidylinositol 3-kinase and the class �� PI3K-C2 alpha. J Biol Chem, 1998,273(40):25987-25995.
[8] Jinquan T, Jing C, Jacobi HH, et al. CXCR3 expression and activation of eosinophils:role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma. J Immunol, 2000,165(3):1548-1556.
[9] Miyamasu M, Yamaguchi M, Nakajima T, et al. Thl-derived cytokine IFN-gamrma is a potent inhibitor of eotaxin synthesis in vitro. Int Immunol,1999, 11(6):1001-1004.
[10] Nakajima T, Yamada H, Likura M, et al. Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett, 1998, 434(3):226-230.
[11] Goebeler M, Yoshimura T, Toksoy A, et al. The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines. J Invest Dermatol, 1997, 108(4):445-451.
[12] Jinquan T, Quan S, Feili G, et al. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4. J Immunol, 1999,162(7):4285-4292.
[13] Schols D, Proost P, Struyf S, et al. CD26-processed RANTES(3-68),but not intact RANTES, has potent anti-HIV-1 activity. Antiviral Res,1998, 39(3):175-187.
[14] Proost P, De Meester I, Schols D, et al. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase ��. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol Chem, 1998, 273(13):7222-7227.
[15] Ebisawa M, Yamada T, Bickel C, et al. Eosinophil transendothelial migration induced by cytokines. H. Effect of the chemokine RANTES. J Immunol, 1994,153(5):2153-2160.
[16] Jinquan T, JacobiHH, Jing C, et al. Chemokine stromal cell-derived factor lalpha activates basophils by means of CXCR4. J Allergy Clin Immunol, 2000, 106(2):313-320.
[17] Teixeira MM, Wells TN, Lukacs NW, et al. Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J Clin Invest, 1997, 100(7):1657-1666.
[18] Sabroe I, Conroy DM, Gerard NP, et al. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3:blockade using a monoclonal antibody in vivo. J Immunol, 1998, 161(11):6139-6147.